Fierce Pharma

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior administration and this administration.” ...

Closing in on a universal vaccine: Nasal spray protects mice from respiratory viruses, bacteria and allergens

In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy ...

Illinois adopts American Academy of Pediatrics vaccine schedule, shunning federal recommendations

Illinois’ adoption of the American Academy of Pediatrics’ childhood vaccine schedule is the latest example of Illinois breaking with the federal government over health care policies.
The New York Times

Three Experts on Vaccines, Measles and Kennedy

So much has changed in American public health under the leadership of Robert F. Kennedy Jr., the secretary of health and human services. Alexandra Sifferlin and Alex Ellerbeck, two editors in Opinion, ...

Vaccine slump risks a downward financial spiral

Pharma groups like $113 bln Sanofi and Pfizer have spent years investing in immunisations. But scepticism from the US ...